Medtronic (MDT)Todd Asset Management LLC reduced its stake -81K shares

849K

Shares reported · -81K vs prior quarter

1.2%

Disclosed portfolio weight

$66.4M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
2. Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
3. May 15, 2026CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
4. Jun 8, 2026Insider · 1 personInsiders: 2 sales (~$337K)
5. Jul 8, 2026InsiderOfficer sold ~$258K of MDT shares in the open market
6. Jul 9, 2026FDAFDA device clearance: SmartGuard Technology; Predictive Low Glucose Technology
7. Jul 13, 2026FDARecall: MiniMed 780G Insulin Pump, Model: MMT-1885CLW, MMT-1886CLW
8. Jul 13, 2026FDARecall: MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
9. Jul 13, 2026FDARecall: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712;
10. Jul 14, 2026FDAFDA device clearance: Symmetrix™ L Spinal System
11. Jul 17, 2026FDAFDA device clearance: Catalyft PL Expandable Interbody System
12. Jul 27, 2026FDAFDA device clearance: Euphora Rapid Exchange (RX) Balloon Dilatation Catheter
13. Jul 30, 2026CongressDisclosed sale of MDT — reported range $1,001 - $15,000
14. Jul 31, 2026FDAFDA device clearance: VitalFlow Set with Balance™ Biosurface

What came next

1. Aug 13, 2026FDAFDA device clearance: BIS™ Advance pEEG Module
2. Aug 14, 2026FDAFDA device clearance: NC Euphora Rapid Exchange Balloon Dilatation Catheter
3. Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
4. Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
5. Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
6. Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
7. Sep 4, 2026FDAFDA device clearance: ApexCut ™ Blade with Automated EM Tracking (187BL4012EM);ApexCut ™ Blade with Automated EM Tracking (187BL4040EM);ApexCut ™ Blade with Automated EM Tracking (1…
8. Sep 15, 2026FDAFDA device clearance: LigaSure™ RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
9. Sep 16, 2026InsiderOfficer sold ~$139K of MDT shares in the open market
10. Sep 17, 2026FDAFDA device clearance: Protégé™ EverFlex™ Self-expanding Peripheral Stent System

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Medtronic

For Medtronic, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 50 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

How this filing works

• SEC Form 13F

Other disclosures at Medtronic

• SEC Form 4Sep 18, 2026
• SEC Form 144Sep 16, 2026
• House Clerk periodic transaction reportSep 1, 2026
• SEC Form 13F-HRAug 26, 2026
• House Clerk periodic transaction reportAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its MDT page.